Slight Guillain-Barré Risk Shouldn't Prevent Vaccination With RZV
While recombinant zoster vaccine (RZV) vaccination against shingles slightly increases the risk of Guillain-Barré syndrome, so does infection with herpes zoster, according to public health officials. Any slightly increased risk of Guillain-Barré syndrome after administration of the RZV is outweighed by the dangers of herpes zoster and its complications, according to a new study. Read more.

Respiratory Syncytial Virus Vaccine Valuable in Older U.S. Cohort
Respiratory syncytial virus (RSV) is often considered problematic only for infants and young children. However, older adults and those with chronic illnesses can also have dire effects—hospitalization and even death—from RSV. Find out how researchers determined the value of a potential vaccine against RSV for the older cohort in a recent study.

Pandemic Sets Back HPV Vaccination to Prevent Oropharyngeal Cancer
The incidence and number of cases of oropharyngeal cancer (OPC) among men now exceed cervical cancer, making OPC the most common human papillomavirus (HPV)–associated cancer. The concern, however, is that the pandemic has slowed efforts to increase uptake of HPV vaccination to a vaccine goal of 80%, which will have a future effect on OPC cases in adult men. Read more.